Alpha 2.0
Login Register
» Articles » PMID: 20789746

B.C.G. and Vole Bacillus Vaccines in the Prevention of Tuberculosis in Adolescence and Early Adult Life

Overview
Journal Br Med J
Specialty General Medicine
Date 2010 Aug 27
PMID 20789746
Citations 8
Affiliations
Soon will be listed here.
Citing Articles

Designing tuberculosis vaccine efficacy trials - lessons from recent studies.

Ginsberg A Expert Rev Vaccines. 2019; 18(5):423-432.

PMID: 30892969 PMC: 6492041. DOI: 10.1080/14760584.2019.1593143.

Safety and immunogenicity of an inactivated whole cell tuberculosis vaccine booster in adults primed with BCG: A randomized, controlled trial of DAR-901.

von Reyn C, Lahey T, Arbeit R, Landry B, Kailani L, Adams L PLoS One. 2017; 12(5):e0175215.

PMID: 28498853 PMC: 5429024. DOI: 10.1371/journal.pone.0175215.

Gene expression and cytokine profile correlate with mycobacterial growth in a human BCG challenge model.

Matsumiya M, Satti I, Chomka A, Harris S, Stockdale L, Meyer J J Infect Dis. 2014; 211(9):1499-509.

PMID: 25381367 PMC: 4392868. DOI: 10.1093/infdis/jiu615.

Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate tuberculosis vaccine, MVA85A, alone and in combination.

Harris S, Meyer J, Satti I, Marsay L, Poulton I, Tanner R J Infect Dis. 2013; 209(8):1259-68.

PMID: 24273174 PMC: 3969545. DOI: 10.1093/infdis/jit647.

Rates of tuberculosis transmission to children and adolescents in a community with a high prevalence of HIV infection among adults.

Middelkoop K, Bekker L, Myer L, Dawson R, Wood R Clin Infect Dis. 2008; 47(3):349-55.

PMID: 18558885 PMC: 3816246. DOI: 10.1086/589750.